Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Claudio Isella

Showing results (41-50 of 64) with videos related to

Pageof 7
Sort By:
Nature Communications|November 11, 2024
Integrative ensemble modelling of cetuximab sensitivity in colorectal cancer patient-derived xenograftsUmberto Perron, Elena Grassi, Aikaterini Chatzipli, et al.
Genome Medicine|June 30, 2019
Evolving neoantigen profiles in colorectal cancers with DNA repair defectsGiuseppe Rospo, Annalisa Lorenzato, Nabil Amirouchene-Angelozzi, et al.
Acta Neuropathologica|January 17, 2025
Concurrent RB1 and P53 pathway disruption predisposes to the development of a primitive neuronal component in high-grade gliomas depending on MYC-driven EBF3 transcriptionFrancesca Pagani, Francesca Orzan, Sara Lago, et al.
Cancers|June 14, 2020
Pazopanib and Trametinib as a Synergistic Strategy against Osteosarcoma: Preclinical Activity and Molecular InsightsGiulia Chiabotto, Giovanni Grignani, Maja Todorovic, et al.
Frontiers in Oncology|September 16, 2022
DNA damage response and repair genes in advanced bone and soft tissue sarcomas: An 8-gene signature as a candidate predictive biomarker of response to trabectedin and olaparib combinationAlessandra Merlini, Maria Laura Centomo, Giulio Ferrero, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 4, 2019
Patient-Derived Xenografts and Matched Cell Lines Identify Pharmacogenomic Vulnerabilities in Colorectal CancerLuca Lazzari, Giorgio Corti, Gabriele Picco, et al.
Cancer Medicine|April 18, 2022
Implementing subtype-specific pre-clinical models of breast cancer to study pre-treatment aspirin effectsIan S Miller, Sonja Khan, Liam P Shiels, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 31, 2011
Genetic and expression analysis of MET, MACC1, and HGF in metastatic colorectal cancer: response to met inhibition in patient xenografts and pathologic correlationsFrancesco Galimi, Davide Torti, Francesco Sassi, et al.
BMC Genomics|February 23, 2022
The EurOPDX Data Portal: an open platform for patient-derived cancer xenograft data sharing and visualizationZdenka Dudová, Nathalie Conte, Jeremy Mason, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 14, 2019
A Subset of Colorectal Cancers with Cross-Sensitivity to Olaparib and OxaliplatinSabrina Arena, Giorgio Corti, Erika Durinikova, et al.
Pageof 7

Showing results (41-50 of 64) with videos related to

Sort By:
Pageof 7
Nature Communications|November 11, 2024
Integrative ensemble modelling of cetuximab sensitivity in colorectal cancer patient-derived xenograftsUmberto Perron, Elena Grassi, Aikaterini Chatzipli, et al.
Genome Medicine|June 30, 2019
Evolving neoantigen profiles in colorectal cancers with DNA repair defectsGiuseppe Rospo, Annalisa Lorenzato, Nabil Amirouchene-Angelozzi, et al.
Acta Neuropathologica|January 17, 2025
Concurrent RB1 and P53 pathway disruption predisposes to the development of a primitive neuronal component in high-grade gliomas depending on MYC-driven EBF3 transcriptionFrancesca Pagani, Francesca Orzan, Sara Lago, et al.
Cancers|June 14, 2020
Pazopanib and Trametinib as a Synergistic Strategy against Osteosarcoma: Preclinical Activity and Molecular InsightsGiulia Chiabotto, Giovanni Grignani, Maja Todorovic, et al.
Frontiers in Oncology|September 16, 2022
DNA damage response and repair genes in advanced bone and soft tissue sarcomas: An 8-gene signature as a candidate predictive biomarker of response to trabectedin and olaparib combinationAlessandra Merlini, Maria Laura Centomo, Giulio Ferrero, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 4, 2019
Patient-Derived Xenografts and Matched Cell Lines Identify Pharmacogenomic Vulnerabilities in Colorectal CancerLuca Lazzari, Giorgio Corti, Gabriele Picco, et al.
Cancer Medicine|April 18, 2022
Implementing subtype-specific pre-clinical models of breast cancer to study pre-treatment aspirin effectsIan S Miller, Sonja Khan, Liam P Shiels, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 31, 2011
Genetic and expression analysis of MET, MACC1, and HGF in metastatic colorectal cancer: response to met inhibition in patient xenografts and pathologic correlationsFrancesco Galimi, Davide Torti, Francesco Sassi, et al.
BMC Genomics|February 23, 2022
The EurOPDX Data Portal: an open platform for patient-derived cancer xenograft data sharing and visualizationZdenka Dudová, Nathalie Conte, Jeremy Mason, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 14, 2019
A Subset of Colorectal Cancers with Cross-Sensitivity to Olaparib and OxaliplatinSabrina Arena, Giorgio Corti, Erika Durinikova, et al.
Pageof 7